Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Elevance Health, Inc. stock logo
ELV
Elevance Health
$384.39
-0.5%
$405.63
$357.45
$567.26
$86.81B0.61.55 million shs383,311 shs
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
$370.20
-0.4%
$357.64
$289.98
$417.14
$89.12B1.491.45 million shs463,833 shs
McKesson Co. stock logo
MCK
McKesson
$728.10
-0.4%
$701.80
$464.42
$732.09
$91.04B0.49917,516 shs257,681 shs
Olympus Co. stock logo
OCPNY
Olympus
$18.00
-1.4%
$18.00
$16.80
$74.99
$23.15B0.7860,265 shs400 shs
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Elevance Health, Inc. stock logo
ELV
Elevance Health
+1.45%+0.40%+2.96%-8.43%-27.22%
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
+1.15%-2.61%+0.84%+16.13%+8.98%
McKesson Co. stock logo
MCK
McKesson
+1.90%+2.78%+6.17%+12.20%+24.93%
Olympus Co. stock logo
OCPNY
Olympus
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Elevance Health, Inc. stock logo
ELV
Elevance Health
4.8893 of 5 stars
4.45.04.20.02.02.52.5
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
4.8334 of 5 stars
2.45.02.54.52.32.52.5
McKesson Co. stock logo
MCK
McKesson
4.3894 of 5 stars
2.43.03.33.02.92.51.3
Olympus Co. stock logo
OCPNY
Olympus
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Elevance Health, Inc. stock logo
ELV
Elevance Health
2.75
Moderate Buy$498.8728.96% Upside
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
2.75
Moderate Buy$392.474.91% Upside
McKesson Co. stock logo
MCK
McKesson
2.87
Moderate Buy$694.38-4.96% Downside
Olympus Co. stock logo
OCPNY
Olympus
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest OCPNY, MCK, HCA, and ELV Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/11/2025
McKesson Co. stock logo
MCK
McKesson
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$745.00 ➝ $770.00
6/9/2025
Elevance Health, Inc. stock logo
ELV
Elevance Health
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Buy$510.00 ➝ $500.00
6/9/2025
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetEqual Weight ➝ Equal Weight$355.00 ➝ $410.00
6/4/2025
Elevance Health, Inc. stock logo
ELV
Elevance Health
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$478.00
6/3/2025
McKesson Co. stock logo
MCK
McKesson
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetEqual Weight ➝ Equal Weight$691.00 ➝ $766.00
6/2/2025
Elevance Health, Inc. stock logo
ELV
Elevance Health
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$522.00 ➝ $480.00
6/2/2025
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
6/2/2025
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetOverweight ➝ Overweight$366.00 ➝ $416.00
5/29/2025
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeUnderweight ➝ Equal Weight$320.00 ➝ $385.00
5/9/2025
McKesson Co. stock logo
MCK
McKesson
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$755.00 ➝ $800.00
4/29/2025
McKesson Co. stock logo
MCK
McKesson
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$708.00 ➝ $805.00
(Data available from 6/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Elevance Health, Inc. stock logo
ELV
Elevance Health
$183.12B0.48$38.80 per share9.97$178.62 per share2.17
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
$71.59B1.26$41.80 per share8.95$2.23 per share167.76
McKesson Co. stock logo
MCK
McKesson
$359.05B0.25$39.75 per share18.38($21.58) per share-33.86
Olympus Co. stock logo
OCPNY
Olympus
$7.74B2.99$1.22 per share14.76$3.50 per share5.14
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Elevance Health, Inc. stock logo
ELV
Elevance Health
$5.98B$25.6315.119.911.183.38%18.28%6.72%7/16/2025 (Estimated)
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
$5.76B$22.4917.0313.351.108.16%586.47%9.93%7/22/2025 (Estimated)
McKesson Co. stock logo
MCK
McKesson
$3.00B$25.8333.4419.941.290.82%-181.26%5.34%8/6/2025 (Estimated)
Olympus Co. stock logo
OCPNY
Olympus
$1.03B$0.8221.9520.691.0713.80%24.30%9.30%N/A

Latest OCPNY, MCK, HCA, and ELV Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2025Q4 2025
McKesson Co. stock logo
MCK
McKesson
$9.83$10.12+$0.29$10.01$94.00 billion$90.82 billion
4/25/2025Q1 2025
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
$5.75$6.45+$0.70$6.45$18.26 billion$18.32 billion
4/22/2025Q1 2025
Elevance Health, Inc. stock logo
ELV
Elevance Health
$10.60$11.97+$1.37$9.61$46.26 billion$48.77 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Elevance Health, Inc. stock logo
ELV
Elevance Health
$6.841.77%N/A26.69%14 Years
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
$2.880.77%N/A12.81%6 Years
McKesson Co. stock logo
MCK
McKesson
$2.840.39%N/A10.99%17 Years
Olympus Co. stock logo
OCPNY
Olympus
$0.080.44%N/A9.76%N/A

Latest OCPNY, MCK, HCA, and ELV Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/1/2025
McKesson Co. stock logo
MCK
McKesson
quarterly$0.710.4%6/2/20256/2/20257/1/2025
4/25/2025
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
quarterly$0.720.84%6/16/20256/16/20256/30/2025
4/23/2025
Elevance Health, Inc. stock logo
ELV
Elevance Health
quarterly$1.711.6%6/10/20256/10/20256/25/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Elevance Health, Inc. stock logo
ELV
Elevance Health
0.71
1.45
1.50
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
69.07
1.08
0.97
McKesson Co. stock logo
MCK
McKesson
N/A
0.88
0.48
Olympus Co. stock logo
OCPNY
Olympus
0.59
1.99
1.48

Institutional Ownership

CompanyInstitutional Ownership
Elevance Health, Inc. stock logo
ELV
Elevance Health
89.24%
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
62.73%
McKesson Co. stock logo
MCK
McKesson
85.07%
Olympus Co. stock logo
OCPNY
Olympus
0.03%

Insider Ownership

CompanyInsider Ownership
Elevance Health, Inc. stock logo
ELV
Elevance Health
0.29%
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
1.30%
McKesson Co. stock logo
MCK
McKesson
0.11%
Olympus Co. stock logo
OCPNY
Olympus
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Elevance Health, Inc. stock logo
ELV
Elevance Health
102,300225.94 million231.11 millionOptionable
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
294,000240.57 million244.37 millionOptionable
McKesson Co. stock logo
MCK
McKesson
75,000125.11 million125.19 millionOptionable
Olympus Co. stock logo
OCPNY
Olympus
31,5571.29 billionN/ANot Optionable

Recent News About These Companies

27 Olympus Way, Lyons ACT 2606
Overwatch 2 Battle for Olympus Event

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Elevance Health stock logo

Elevance Health NYSE:ELV

$384.42 -1.80 (-0.47%)
As of 03:25 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits. The company operates in the pharmacy services business; and markets and offers pharmacy services, including pharmacy benefit management, as well as home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services. In addition, it provides healthcare-related services and capabilities, including utilization management, behavioral health, integrated care delivery, palliative care, payment integrity services, subrogation services, and health and wellness programs, as well as services related to data management, information technology, and business operations. Further, the company is involved in the National Government Services business. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brand names. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.

HCA Healthcare stock logo

HCA Healthcare NYSE:HCA

$370.20 -1.48 (-0.40%)
As of 03:25 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

HCA Healthcare, Inc., through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, it operates behavioral hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.

McKesson stock logo

McKesson NYSE:MCK

$728.10 -2.70 (-0.37%)
As of 03:25 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Olympus stock logo

Olympus OTCMKTS:OCPNY

$18.00 -0.25 (-1.37%)
As of 01/31/2023

Olympus Corp. engages in the manufacture and sale of precision machineries and instruments. It operates through the following segments: Medical, Scientific Solutions, Imaging, and Others. The Medical segment covers digestive, surgical, and ultrasonic endoscopy as well as endoscopic treatment tools. The Scientific Solutions segment manufactures and sells biological and industrial microscopes, industrial endoscopes, and non-destructive testing equipment. The Imaging segment deals with digital cameras and recording devices. The Others segment includes biomaterial manufacturing and sales business. The company was founded by Takeshi Yamashita on October 12, 1919 and is headquartered in Tokyo, Japan.